Context Matters: the Hen or Egg Problem in Ewing's Sarcoma
Overview
Authors
Affiliations
Ewing's sarcoma and related tumors (ESFT) are characterized by rearrangements of EWS with ets family genes. While detection of these gene fusions greatly facilitated diagnosis, it has not provided any clues about the tissue of origin. Immunological and gene expression profiling studies favour a neuroectodermal histogenesis. These investigations did not appreciate the impact of EWS-ets proteins on the tumor phenotype. Introduction of EWS-ets into different cellular models resulted in diverse outcomes ranging from the induction of cell cycle arrest or apoptosis to transformation and tumorigenicity, and from blocked differentiation to trans-differentiation. Thus, the molecular signature of EWS-ets proteins depends on the cell type. The hen or egg problem in ESFT, therefore, is whether ESFT reflect the phenotype of the tumor stem cell that is blocked in differentiation by the activity of the EWS-ets gene fusion or if the oncogene imposes an incomplete differentiation program on a pluripotent precursor cell. This article addresses the problem by considering the tissue distribution of FLI1 and ERG expression and by reviewing evidence for combinatorial control of EWS-ets activity.
Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment.
Pachva M, Lai H, Jia A, Rouleau M, Sorensen P Front Cell Dev Biol. 2021; 9:726205.
PMID: 34604225 PMC: 8484747. DOI: 10.3389/fcell.2021.726205.
Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells.
El Beaino M, Liu J, Wasylishen A, Pourebrahim R, Migut A, Bessellieu B BMC Cancer. 2020; 20(1):3.
PMID: 31898537 PMC: 6941350. DOI: 10.1186/s12885-019-6465-8.
Nan X, Wang J, Cheng H, Yin Z, Sheng J, Qiu B Cancer Lett. 2019; 469:195-206.
PMID: 31672491 PMC: 6905085. DOI: 10.1016/j.canlet.2019.10.034.
EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma.
Sun W, Rojas Y, Wang H, Yu Y, Wang Y, Chen Z Oncotarget. 2017; 8(55):94780-94792.
PMID: 29212266 PMC: 5706912. DOI: 10.18632/oncotarget.21933.
The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.
Schwentner R, Herrero-Martin D, Kauer M, Mutz C, Katschnig A, Sienski G Oncotarget. 2016; 8(7):10980-10993.
PMID: 28030800 PMC: 5355239. DOI: 10.18632/oncotarget.14091.